428 related articles for article (PubMed ID: 32443747)
1. Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?
Mocan T; Simão AL; Castro RE; Rodrigues CMP; Słomka A; Wang B; Strassburg C; Wöhler A; Willms AG; Kornek M
J Clin Med; 2020 May; 9(5):. PubMed ID: 32443747
[TBL] [Abstract][Full Text] [Related]
2. Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis.
De Rubis G; Rajeev Krishnan S; Bebawy M
Trends Pharmacol Sci; 2019 Mar; 40(3):172-186. PubMed ID: 30736982
[TBL] [Abstract][Full Text] [Related]
3. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
[TBL] [Abstract][Full Text] [Related]
4. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis.
Wu J; Hu S; Zhang L; Xin J; Sun C; Wang L; Ding K; Wang B
Theranostics; 2020; 10(10):4544-4556. PubMed ID: 32292514
[TBL] [Abstract][Full Text] [Related]
5. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
[TBL] [Abstract][Full Text] [Related]
6. Liquid Biopsy in Prostate Cancer Management-Current Challenges and Future Perspectives.
Crocetto F; Russo G; Di Zazzo E; Pisapia P; Mirto BF; Palmieri A; Pepe F; Bellevicine C; Russo A; La Civita E; Terracciano D; Malapelle U; Troncone G; Barone B
Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805043
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Ye Q; Ling S; Zheng S; Xu X
Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
[TBL] [Abstract][Full Text] [Related]
8. Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?
Pelizzaro F; Cardin R; Penzo B; Pinto E; Vitale A; Cillo U; Russo FP; Farinati F
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34068786
[TBL] [Abstract][Full Text] [Related]
9. Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy.
Maravelia P; Silva DN; Rovesti G; Chrobok M; Stål P; Lu YC; Pasetto A
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503144
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicle-based liquid biopsies in cancer: Future biomarkers for oral cancer.
Minami S; Chikazu D; Ochiya T; Yoshioka Y
Transl Oncol; 2023 Dec; 38():101786. PubMed ID: 37713973
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsies.
Lianidou E; Pantel K
Genes Chromosomes Cancer; 2019 Apr; 58(4):219-232. PubMed ID: 30382599
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors.
Ravegnini G; Sammarini G; Serrano C; Nannini M; Pantaleo MA; Hrelia P; Angelini S
Ther Adv Med Oncol; 2019; 11():1758835919831902. PubMed ID: 30854029
[TBL] [Abstract][Full Text] [Related]
14. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Li J; Han X; Yu X; Xu Z; Yang G; Liu B; Xiu P
J Exp Clin Cancer Res; 2018 Sep; 37(1):213. PubMed ID: 30176913
[TBL] [Abstract][Full Text] [Related]
15. Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers.
Yin CQ; Yuan CH; Qu Z; Guan Q; Chen H; Wang FB
Dis Markers; 2016; 2016():1427849. PubMed ID: 27403030
[TBL] [Abstract][Full Text] [Related]
16. Current Applications of Liquid Biopsy in Gastrointestinal Cancer Disease-From Early Cancer Detection to Individualized Cancer Treatment.
David P; Mittelstädt A; Kouhestani D; Anthuber A; Kahlert C; Sohn K; Weber GF
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046585
[TBL] [Abstract][Full Text] [Related]
17. Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes.
Nimir M; Ma Y; Jeffreys SA; Opperman T; Young F; Khan T; Ding P; Chua W; Balakrishnar B; Cooper A; De Souza P; Becker TM
Cells; 2019 Jul; 8(7):. PubMed ID: 31288377
[TBL] [Abstract][Full Text] [Related]
18. Clinical Application of Different Liquid Biopsy Components in Hepatocellular Carcinoma.
Xu J; Zhao Y; Chen Z; Wei L
J Pers Med; 2024 Apr; 14(4):. PubMed ID: 38673047
[TBL] [Abstract][Full Text] [Related]
19. The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer.
Riethdorf S; Soave A; Rink M
Transl Androl Urol; 2017 Dec; 6(6):1090-1110. PubMed ID: 29354496
[TBL] [Abstract][Full Text] [Related]
20. The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma.
Lee YT; Tran BV; Wang JJ; Liang IY; You S; Zhu Y; Agopian VG; Tseng HR; Yang JD
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
